Abstract
Neurofibromatosis 2 (NF2) is caused by inactivating mutations of the NF2 tumor suppressor gene. Somatic NF2 mutations also occur in a high proportion of human primary malignant mesotheliomas. We report an elderly man with NF2, malignant mesothelioma, and a constitutional NF2 missense mutation. The long latent period for mesothelioma in this patient (61 years) raises the possibility that the type of mutant NF2 allele could affect mesothelioma tumorigenesis or progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
JA Trofatter MM MacCollin JL Rutter et al. (1993) ArticleTitleA novel moesin-ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor (published erratum appears in Cell 1993; 75: 826) Cell 72 791–800 Occurrence Handle10.1016/0092-8674(93)90406-G Occurrence Handle8453669 Occurrence Handle1:CAS:528:DyaK3sXisFagt78%3D
GA Rouleau P Mérel M Lutchman et al. (1993) ArticleTitleAlteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2 Nature 363 515–21 Occurrence Handle10.1038/363515a0 Occurrence Handle8379998 Occurrence Handle1:CAS:528:DyaK3sXltlKmsbg%3D
AB Bianchi SI Mitsunaga JQ Cheng et al. (1995) ArticleTitleHigh frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas Proc Natl Acad Sci USA. 92 10854–8 Occurrence Handle7479897 Occurrence Handle1:CAS:528:DyaK2MXps1amtbk%3D
M Carbone RA Kratzke JR Testa (2002) ArticleTitleThe pathogenesis of mesothelioma Semin Oncol 29 1–17 Occurrence Handle10.1053/sonc.2002.30227
ME Baser A De Rienzo D Altomare et al. (2002) ArticleTitleNeurofibromatosis 2 and malignant mesothelioma Neurology 359 290–1
Baser ME. Neurofibromatosis 2 (NF2) databases. Human Gene Mutation Database 2004. http://uwcmml1s.uwcm.ac.uk/uwcm/mg/nf2/.
DG Evans SM Huson D Donnai et al. (1992) ArticleTitleA genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity J Med Genet 29 841–7 Occurrence Handle1479598 Occurrence Handle1:STN:280:ByyC38vkslc%3D
RR Connelly R Spirtas MH Myers CL Percy JF Fraumeni SuffixJr (1987) ArticleTitleDemographic patterns for mesothelioma in the United States J Natl Cancer Inst 78 1053–60 Occurrence Handle3473246 Occurrence Handle1:STN:280:BiiB38nps1M%3D
A Knudson (1995) ArticleTitleAsbestos and mesothelioma: Genetic lessons from a tragedy Proc Natl Acad Sci USA 92 10819–20 Occurrence Handle7479890 Occurrence Handle1:CAS:528:DyaK2MXps1amtb4%3D
J Fleury-Feith C Lecomte A Renier et al. (2003) ArticleTitleHemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumors Oncogene 22 3799–805 Occurrence Handle10.1038/sj.onc.1206593 Occurrence Handle12802287 Occurrence Handle1:CAS:528:DC%2BD3sXksV2jurg%3D
JQ Cheng W-C Lee MA Klein GZ Cheng SC Jhanwar JR Testa (1999) ArticleTitleFrequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation Genes Chromosomes Cancer 24 238–42 Occurrence Handle10.1002/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M Occurrence Handle10451704 Occurrence Handle1:CAS:528:DyaK1MXht1entbY%3D
ME Baser JM Friedman D Aeschliman et al. (2002) ArticleTitlePredictors of the risk of mortality in neurofibromatosis 2 Am J Hum Genet 71 715–23 Occurrence Handle10.1086/342716 Occurrence Handle12235555
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baser, M., Rai, H., Wallace, A. et al. Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation. Familial Cancer 4, 321–322 (2005). https://doi.org/10.1007/s10689-005-0659-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10689-005-0659-8